Stay updated on Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Pembrolizumab in RCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe page now loads a 403 Forbidden error instead of the expected study record, indicating that access to the page is blocked. The view shows the 403 message along with the site's header and footer, reflecting an access restriction rather than a modification to the study data.SummaryDifference18%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.6.6 was added, replacing the previous v3.6.5. This reflects an update to the page's revision metadata rather than changes to the study data.SummaryDifference0.1%

- Check38 days agoChange DetectedThe study's identifiers section includes a new line documenting an NIH grant/contract (2016). This addition records funding information as part of the study's administrative identifiers.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous revision and indicating deployment of the latest site build.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 in the page footer, representing an internal software update. The public study details and navigation remain unchanged.SummaryDifference0.1%

- Check88 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, reflecting a new version of the page's documentation. It does not modify the study content or any user-facing information on the page.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in RCC Clinical Trial page.